No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US OptionsDetailed Quotes
XRAY240816C25000
- 2.15
- +0.03+1.42%
15min DelayClose Jul 22 15:59 ET
2.20High1.90Low
1.90Open2.12Pre Close133 Volume266 Open Interest25.00Strike Price28.35KTurnover44.60%IV2.88%PremiumAug 16, 2024Expiry Date1.39Intrinsic Value100Multiplier24DDays to Expiry0.76Extrinsic Value100Contract SizeAmericanOptions Type0.7098Delta0.1113Gamma12.72Leverage Ratio-0.0237Theta0.0114Rho9.03Eff Leverage0.0236Vega
Intraday
- 5D
- Daily
News
Dentsply Sirona Is Maintained at Neutral by Baird
Dentsply Sirona Is Maintained at Neutral by
Dentsply Sirona Price Target Cut to $31.00/Share From $33.00 by Baird
Dentsply Sirona Price Target Cut to $31.00/Share From $33.00 by
Baird Maintains Dentsply Sirona(XRAY.US) With Hold Rating, Cuts Target Price to $31
Baird analyst Jeff Johnson maintains $Dentsply Sirona(XRAY.US)$ with a hold rating, and adjusts the target price from $33 to $31.According to TipRanks data, the analyst has a success rate of 52.8%
Brazil Dental Prosthetics Market Size, Share & Trends Analysis 2024-2030, Featuring Dentsply Sirona, Ivoclar, VITA and Kulzer
Is DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Trading At A 31% Discount?
Key Insights DENTSPLY SIRONA's estimated fair value is US$38.19 based on 2 Stage Free Cash Flow to Equity Current share price of US$26.36 suggests DENTSPLY SIRONA is potentially 31% undervalued
Dentsply Sirona Is Maintained at Hold by Stifel
Dentsply Sirona Is Maintained at Hold by
Comments
The company's low growth and lack of profits have led to a stock price drop. A revenue growth acceleration might boost the share price. However, the real benefit for shareholders will be if the company starts making profits. Despite recent gains, the returns over the last three years have been disappointing.
DENTSPLY SIRONA (NASDAQ:XRAY) Shareholders Have Endured a 32% Loss From Investing in the Stock Three Years Ago 1
DENTSPLY SIRONA's decreasing capital employment and flat returns are concerning. The stock's decline may reflect investor pessimism about these trends. The analysis does not see the traits of a multi-bagger in this stock.
DENTSPLY SIRONA's decision to pay a dividend amidst a reported loss is unsettling. It's not an ideal choice for long-term buy and hold investors.
1
Investors predict limited future growth for the company, reflected by its low P/S ratio. The pessimism around its revenue prospect contributes to its undervalued stock.
DENTSPLY SIRONA, currently undervalued with steady price trends, could make a solid investment. Despite modest growth projections, aspects like capital structure and management track record could be behind its undervaluation.
Read more